Trial Profile
Medium-dose losartan/hydrochlorothiazide vs maximal dose angiotensin receptor antagonists in patients with hypertension uncontrolled on medium-dose angiotensin receptor antagonists
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Mar 2013
Price :
$35
*
At a glance
- Drugs Losartan/hydrochlorothiazide (Primary) ; Angiotensin receptor antagonists
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms Kobe-CONNECT
- 17 Mar 2013 New trial record